Nirmatrelvir
Stock Recap #PipelineProspector

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

In October, several pharma companies posted their third quarter (Q3) results. Drugmakers like Pfizer

Pipeline Prospector June 2024: FDA approves Merck’s next-gen pneumococcal vaccine, Verona’s COPD therapy

The pharma indices were back in the black in May, and the good streak continued through June with th

Pipeline Prospector Jan 2024: Vertex’s non-opioid painkiller succeeds in trials; Sanofi buys Inhibrx for US$ 2.2 bn

The New Year got off to a stable start, with some good news trickling in from clinical trials and B

Pipeline Prospector Jan 2023: Mega cap drugmakers face rout at bourses even as biotech indices inch upwards

After facing the worst year since 2008, biotech indices opened 2023 on a positive note. All the thre